J&J seeking 20,000 Covid vaccine trial volunteers in hard-hit Latin America


By Aislinn Laing SANTIAGO (Reuters) - Johnson & Johnson will seek 20,000 volunteers for late-stage human trials of its experimental coronavirus vaccine in hard-hit Latin America, one-third of the planned global total, one of its public health chiefs in the region said.

Josue Bacaltchuk, vice president of medical affairs for Latin America for Janssen, J&J's Belgian unit developing the vaccine prototype, said countries hosting the trials would also likely get preferential access to vaccines once ready. "We expect the majority.....

This article is no longer available in our repository.

There could be multiple reasons for this.